Nantahala Capital Management, LLC Anebulo Pharmaceuticals, Inc. Put Options Transaction History
Nantahala Capital Management, LLC
- $1.99 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ANEB
# of Institutions
16Shares Held
9.92MCall Options Held
0Put Options Held
0-
22 Nw, LP Seattle, WA15.5MShares$20.6 Million21.77% of portfolio
-
Mangrove Partners New York, NY2.53MShares$3.36 Million0.66% of portfolio
-
Lvw Advisors, LLC633KShares$841,2460.13% of portfolio
-
Morgan Stanley New York, NY420KShares$558,5920.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX158KShares$209,7670.04% of portfolio
About Anebulo Pharmaceuticals, Inc.
- Ticker ANEB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,633,200
- Market Cap $34.1M
- Description
- Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The ...